Quick Takeaways: Why It Matters? ALA-1000’s data support a true once-monthly, long-acting analgesic option, which could meaningfully shift osteoarthritis pain management away from daily oral medications in suitable dogs. If approved, the combination of dura...
Quick Takeaways: Why It Matters? The renewed partnership reinforces Royal Canin’s positioning as a science-first leader in obesity and weight-management diets, backed by real-world clinical outcomes from an academic center. By combining low-cost clinical care with precisio...
Tanya: Tell us about your background and what led you to animal health innovation. Jamie: My career has focused on advancing precision molecular technologies, particularly in genomics and targeted protein analysis. I’ve spent more than two decades working at the intersection of science, tr...
ANIMALHEALTHX Weekly is your weekly pulse on the global animal health industry, delivering curated insights, executive interviews, regulatory updates, innovation breakthroughs, and market movements shaping the future of veterinary medicine and animal care. Cover Story Pawsible Ventures Lau...
Quick Takeaways: Why It Matters? The strong equine proof‑of‑concept data, clean safety profile, and upcoming human knee OA feasibility study collectively de‑risk Hydrocelin’s translational path, increasing its attractiveness as a first‑in‑class, potentially disease‑mo...
Quick Takeaways: Why It Matters? The USDA’s positive safety verdict for Ecovaxxin MG significantly de‑risks US registration, validating ECO’s live‑strain platform and setting up a clear path toward a 2027 filing in a large Mycoplasma gallisepticum market.&nb...
Quick Takeaways: Why It Matters? Relocating the HQ to Boston embeds Dechra in a top-tier life sciences cluster, improving access to R&D talent, BD opportunities, and capital for innovation-driven growth. The shift also signals a stronger strategic emphasis on...
Quick Takeaways: Why It Matters? HereFurYou strengthens Thrive’s membership value by adding always-on clinical support, making its ecosystem more “sticky” versus standalone brick-and-mortar clinics and insurers. By absorbing a portion of afte...
Quick Takeaways: Why It Matters? MiDOG’s expanded WGS panel positions it as a high-end reference option for difficult, polymicrobial, or refractory cases, where traditional culture and targeted PCR often fall short. By consolidating bacteria, fungi...
Quick Takeaways: Why It Matters? The partnership gives Gallant industrial‑grade cold-chain logistics, solving a key bottleneck for scaling allogeneic cell therapies beyond a few specialty centers. For MWI/Cencora, establishing -80°C capability positions the ...